142 related articles for article (PubMed ID: 37690821)
21. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
Barnes J; Anderson LA; Phillipson JD
J Pharm Pharmacol; 2001 May; 53(5):583-600. PubMed ID: 11370698
[TBL] [Abstract][Full Text] [Related]
22. Cellular mechanisms and prospective applications of hypericin in photodynamic therapy.
Kiesslich T; Krammer B; Plaetzer K
Curr Med Chem; 2006; 13(18):2189-204. PubMed ID: 16918348
[TBL] [Abstract][Full Text] [Related]
23. Hypericin-loaded lipid nanocapsules for photodynamic cancer therapy in vitro.
Barras A; Boussekey L; Courtade E; Boukherroub R
Nanoscale; 2013 Nov; 5(21):10562-72. PubMed ID: 24056802
[TBL] [Abstract][Full Text] [Related]
24. Hypericin in cancer treatment: more light on the way.
Agostinis P; Vantieghem A; Merlevede W; de Witte PA
Int J Biochem Cell Biol; 2002 Mar; 34(3):221-41. PubMed ID: 11849990
[TBL] [Abstract][Full Text] [Related]
25. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
Wang EJ; Barecki-Roach M; Johnson WW
J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009
[TBL] [Abstract][Full Text] [Related]
26. Hypericin-assisted photodynamic therapy against anaplastic thyroid cancer.
Kim H; Kim SW; Seok KH; Hwang CW; Ahn JC; Jin JO; Kang HW
Photodiagnosis Photodyn Ther; 2018 Dec; 24():15-21. PubMed ID: 30118906
[TBL] [Abstract][Full Text] [Related]
27. Jasmonic acid-induced hypericin production in cell suspension cultures of Hypericum perforatum L. (St. John's wort).
Walker TS; Pal Bais H; Vivanco JM
Phytochemistry; 2002 Jun; 60(3):289-93. PubMed ID: 12031448
[TBL] [Abstract][Full Text] [Related]
28. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
Vacek J; Klejdus B; Kubán V
Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
[TBL] [Abstract][Full Text] [Related]
29. Phototoxicity in human lens epithelial cells promoted by St. John's Wort.
He YY; Chignell CF; Miller DS; Andley UP; Roberts JE
Photochem Photobiol; 2004; 80(3):583-6. PubMed ID: 15623347
[TBL] [Abstract][Full Text] [Related]
30. Effect of St. John's Wort standardized extract and hypericin on in vitro placental calcium transport.
da Conceição AO; Takser L; Lafond J
J Med Food; 2010 Aug; 13(4):934-42. PubMed ID: 20553141
[TBL] [Abstract][Full Text] [Related]
31. Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines.
Hostanska K; Reichling J; Bommer S; Weber M; Saller R
Eur J Pharm Biopharm; 2003 Jul; 56(1):121-32. PubMed ID: 12837490
[TBL] [Abstract][Full Text] [Related]
32. Hypericins as potential leads for new therapeutics.
Karioti A; Bilia AR
Int J Mol Sci; 2010 Feb; 11(2):562-94. PubMed ID: 20386655
[TBL] [Abstract][Full Text] [Related]
33. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
[TBL] [Abstract][Full Text] [Related]
34. In vitro photodynamic therapy in pediatric epithelial liver tumors promoted by hypericin.
Seitz G; Krause R; Fuchs J; Heitmann H; Armeanu S; Ruck P; Warmann SW
Oncol Rep; 2008 Nov; 20(5):1277-82. PubMed ID: 18949433
[TBL] [Abstract][Full Text] [Related]
35. Development of new and validated HPTLC methods for the qualitative and quantitative analysis of hyperforin, hypericin and hyperoside contents in Hypericum species.
Saçıcı E; Yesilada E
Phytochem Anal; 2022 Apr; 33(3):355-364. PubMed ID: 34734668
[TBL] [Abstract][Full Text] [Related]
36. Hypericin, the active component of St. John's wort, inhibits glutamate release in the rat cerebrocortical synaptosomes via a mitogen-activated protein kinase-dependent pathway.
Chang Y; Wang SJ
Eur J Pharmacol; 2010 May; 634(1-3):53-61. PubMed ID: 20193678
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of action of St John's wort in depression : what is known?
Butterweck V
CNS Drugs; 2003; 17(8):539-62. PubMed ID: 12775192
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic-free nanotherapeutics: hypericin nanoparticles thereof for improved in vitro and in vivo antimicrobial photodynamic therapy and wound healing.
Nafee N; Youssef A; El-Gowelli H; Asem H; Kandil S
Int J Pharm; 2013 Sep; 454(1):249-58. PubMed ID: 23834835
[TBL] [Abstract][Full Text] [Related]
39. Natural constituents of St. John's Wort inhibit the proteolytic activity of human thrombin.
Wei LH; Chen TR; Fang HB; Jin Q; Zhang SJ; Hou J; Yu Y; Dou TY; Cao YF; Guo WZ; Ge GB
Int J Biol Macromol; 2019 Aug; 134():622-630. PubMed ID: 31047931
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial photodynamic therapy against Propionibacterium acnes biofilms using hypericin (Hypericum perforatum) photosensitizer: in vitro study.
Barroso RA; Navarro R; Tim CR; de Paula Ramos L; de Oliveira LD; Araki ÂT; Fernandes KGC; Macedo D; Assis L
Lasers Med Sci; 2021 Aug; 36(6):1235-1240. PubMed ID: 33083912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
